These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 12651177
1. How many claudicants should be prescribed statins? Harrison EM, Holdsworth RJ. Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):367-8. PubMed ID: 12651177 [No Abstract] [Full Text] [Related]
2. Intermittent claudication: a plea for guidelines for medical management. Powell JT. Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850 [No Abstract] [Full Text] [Related]
3. How many claudicants should be prescribed statins? Hobbs SD, Wilmink T, Bradbury AW. Eur J Vasc Endovasc Surg; 2003 Jul; 26(1):110. PubMed ID: 12819659 [No Abstract] [Full Text] [Related]
4. Re: Secondary medical prevention in patients with peripheral arterial disease. Schouten O, Welten GM, Bax JJ, Poldermans D. Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805 [No Abstract] [Full Text] [Related]
6. Optimal medical management of peripheral arterial disease. Rice TW, Lumsden AB. Vasc Endovascular Surg; 2006 Jul 05; 40(4):312-27. PubMed ID: 16959725 [Abstract] [Full Text] [Related]
7. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction. Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP. Eur J Vasc Endovasc Surg; 2008 Jan 05; 35(1):51-8. PubMed ID: 17923426 [Abstract] [Full Text] [Related]
8. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events. Coppola G, Novo S. Arch Med Res; 2007 Jul 05; 38(5):479-88. PubMed ID: 17560452 [Abstract] [Full Text] [Related]
9. Lipid-lowering therapy in patients with peripheral arterial disease. Collins P, Brittenden J. Vasc Med; 2004 Nov 05; 9(4):303-6. PubMed ID: 15678623 [No Abstract] [Full Text] [Related]
11. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease. Poussa H, Strandberg TE, Tikkanen I, Kauhanen P, Lepäntalo M. Scand Cardiovasc J; 2007 Jun 05; 41(3):138-41. PubMed ID: 17487761 [Abstract] [Full Text] [Related]
12. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up. Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA. Interact Cardiovasc Thorac Surg; 2008 Apr 05; 7(2):231-4. PubMed ID: 18234766 [Abstract] [Full Text] [Related]
13. Control of hypertension in patients with peripheral artery disease. Clement DL. Blood Press; 2006 Apr 05; 15(4):251-2. PubMed ID: 17078187 [No Abstract] [Full Text] [Related]
14. Evaluation of a drug-drug interaction alert structure through the retrospective analysis of statins-macrolides co-prescriptions. Morera T, Gervasini G, Carrillo JA, Benitez J. Basic Clin Pharmacol Toxicol; 2005 Apr 05; 96(4):289-94. PubMed ID: 15755311 [Abstract] [Full Text] [Related]
15. Prescription of teratogenic medications in United States ambulatory practices. Schwarz EB, Maselli J, Norton M, Gonzales R. Am J Med; 2005 Nov 05; 118(11):1240-9. PubMed ID: 16271908 [Abstract] [Full Text] [Related]
16. Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities. Gnavi R, Migliardi A, Demaria M, Petrelli A, Caprioglio A, Costa G. Eur J Public Health; 2007 Oct 05; 17(5):492-6. PubMed ID: 17303583 [Abstract] [Full Text] [Related]
17. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation. Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM. Ann Vasc Surg; 2007 Mar 05; 21(2):163-6. PubMed ID: 17349357 [Abstract] [Full Text] [Related]